当前位置:首页 - 行情中心 - 祥生医疗(688358) - 财务分析 - 现金流量表

祥生医疗

(688358)

  

流通市值:38.68亿  总市值:38.68亿
流通股本:1.12亿   总股本:1.12亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金323,526,251.41214,839,726.77104,290,612.93482,730,056.4
  收到的税费返还24,160,075.3412,479,795.967,252,718.4330,730,698.78
  收到其他与经营活动有关的现金26,391,904.0815,213,442.826,975,630.232,537,898.73
  经营活动现金流入小计374,078,230.83242,532,965.55118,518,961.56545,998,653.91
  购买商品、接受劳务支付的现金139,883,510.9482,668,074.2933,489,392.85201,445,688.08
  支付给职工以及为职工支付的现金94,581,881.567,540,493.340,690,162.95131,751,226.19
  支付的各项税费20,277,452.0213,477,688.212,936,652.7828,311,043.61
  支付其他与经营活动有关的现金46,045,103.4625,142,901.3720,367,744.2143,807,374.18
  经营活动现金流出小计300,787,947.92188,829,157.1797,483,952.79405,315,332.06
  经营活动产生的现金流量净额73,290,282.9153,703,808.3821,035,008.77140,683,321.85
二、投资活动产生的现金流量:
  收回投资收到的现金1,278,486,349.35860,658,200425,093,7003,087,362,797
  取得投资收益收到的现金3,193,084.122,124,549.261,146,697.816,669,508.67
  处置固定资产、无形资产和其他长期资产收回的现金净额4,270,315.313,718,714.531,198,017.635,005,707.16
  收到的其他与投资活动有关的现金5,014,073.393,510,741.511,748,099.7817,008,819.07
  投资活动现金流入小计1,290,963,822.17870,012,205.3429,186,515.223,116,046,831.9
  购建固定资产、无形资产和其他长期资产支付的现金12,760,925.5512,049,589.944,191,264.798,852,968.36
  投资支付的现金1,250,535,421.36843,552,100415,492,221.362,551,667,730
  投资活动现金流出小计1,263,296,346.91855,601,689.94419,683,486.152,560,520,698.36
  投资活动产生的现金流量净额27,667,475.2614,410,515.369,503,029.07555,526,133.54
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金111,874,753--89,499,802.4
  支付其他与筹资活动有关的现金4,116,634.671,990,208.21,188,099.894,302,479.29
  筹资活动现金流出小计115,991,387.671,990,208.21,188,099.8993,802,281.69
  筹资活动产生的现金流量净额-115,991,387.67-1,990,208.2-1,188,099.89-93,802,281.69
四、汇率变动对现金及现金等价物的影响-4,939,828.76-3,633,007.03-447,166.4212,237,748.7
五、现金及现金等价物净增加额-19,973,458.2662,491,108.5128,902,771.53614,644,922.4
  加:期初现金及现金等价物余额818,703,836.07818,663,322.05818,703,836.09204,018,399.65
  期末现金及现金等价物余额798,730,377.81881,154,430.56847,606,607.62818,663,322.05
补充资料:
  净利润-69,696,320.88-140,505,142.58
  资产减值准备-2,501,971.97-4,561,745.68
  固定资产和投资性房地产折旧-5,508,480.04-10,791,196.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-5,508,480.04-10,791,196.84
  无形资产摊销-521,317.64-927,007.88
  长期待摊费用摊销-120,903.9-257,339.55
  处置固定资产、无形资产和其他长期资产的损失--3,156,901.27--4,612,503.98
  公允价值变动损失--95,763.77--170,984.75
  财务费用--1,319,547.47--21,746,750.08
  投资损失--1,953,564.51--6,119,986.84
  递延所得税--455,259.97-815,269.64
  其中:递延所得税资产减少--455,259.97-815,269.64
  存货的减少-9,058,375.24-5,653,435.03
  经营性应收项目的减少--27,477,098.85--1,014,291.14
  经营性应付项目的增加--4,004,611.99-7,833,923.56
  其他-1,168,258.51--2,028,192.09
  现金的期末余额-881,154,430.56-818,663,322.05
  减:现金的期初余额-818,663,322.05-204,018,399.65
  现金及现金等价物的净增加额-62,491,108.51-614,644,922.4
公告日期2025-10-202025-08-292025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑